Benign Prostatic Hyperplasia News and Research

RSS

Kidney disease associated with 'benign' prostate obstruction

Men who experience signs and symptoms of a prostate obstruction resulting from benign prostatic hyperplasia (BPH) are three times more likely than other men to develop chronic kidney disease, according to findings of a Mayo Clinic study published in this month's edition of Kidney International.

29 Jun 2005

What should you do - if anything - to treat an enlarged prostate gland?

Called benign prostatic hyperplasia or hypertrophy (BPH), the condition affects most men as they age. About half of men with an enlarged prostate seek medical treatment because of bothersome urinary tract symptoms. These symptoms may include poor urine flow, straining to urinate, frequent urination and urinary urgency.

25 May 2005

Men being treated with alpha-blockers for an enlarged prostate may not have to endure sexual dysfunction

Research conducted by Hellstrom comparing the impact of two commonly prescribed medications on men's ability to ejaculate was presented today at the 100th annual meeting of the American Urological Association May 23.

23 May 2005

Practical lifestyle tips that can ease living with prostate problems

Symptoms of an enlarged prostate — known medically as benign prostatic hyperplasia (BPH) — can range from a weak, slow urinary stream, to hesitancy and straining to urinate, to an inability to empty the bladder completely, to more serious complications including recurrent urinary tract infections and kidney damage.

29 Oct 2004

PSA test is now all but useless for predicting prostate cancer risk

The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine researchers.

10 Sep 2004

Study to compare prostate surgery and drugs

The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.

20 Aug 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004

Botox shows promise as an alternative treatment for benign prostatic hyperplasia

Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.

11 May 2004

Sexual Dysfunction in benign prostatic hyperplasia (BPH) twice as high as physicians estimate

The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or enlarged prostate -- is nearly twice as high as treating physicians believe shows a new survey from the American Foundation for Urologic Diseases (AFUD) presented today at the American Urological Association annual meeting.

11 May 2004

Relationship between PSA score and prostate cancer has steadily declined

Results of a new study indicate that the relationship between PSA score and prostate cancer has steadily declined during the last 20 years, an important finding given that PSA score is often used to determine whether biopsy for prostate cancer testing is necessary.

10 May 2004

FDA Approves PROSCAR® Combined With Doxazosin to Reduce the Risk of Benign Prostatic Hyperplasia Symptoms

Merck & Co., Inc. today announced that the Food and Drug Administration (FDA) has approved changes to the prescribing information for PROSCAR® (finasteride) based on a landmark National Institutes of Health (NIH) study.

20 Apr 2004

Study suggests ways to prevent prostate cancer

Current information on prostate cancer risk factors suggests that some cases might be prevented. One possible risk factor that can be changed is diet. You may be able to reduce your risk of prostate cancer by changing the way you eat.

11 Apr 2004

Alfuzosin, new treatment for Acute Urinary Retention

The results of the ALFAUR (ALFuzosin in Acute Urinary Retention) study, announced today at the XIXth European Association of Urology (EAU) Congress in Vienna, Austria, indicate that the uroselective alpha1-blocker alfuzosin 10 mg once daily (OD) may have a beneficial effect in the management of male patients suffering from acute urinary retention (AUR), a sudden inability to pass urine that results in a painful distension of the bladder, requires immediate management with urethral catheterization and could necessitate surgical intervention.

25 Mar 2004